VNDA
Vanda Pharmaceuticals Inc
5.10$
+0.4%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +119.2% | +32.8% | +13.1% | +17.0% | +17.6% | +9.2% | +8.3% | -5.3% | -24.3% | +3.2% | +8.7% | |
| – | +1,382.1% | +5.3% | -27.8% | +14.9% | +19.4% | -4.6% | +9.7% | -5.3% | -27.6% | -35.6% | +15.3% | |
| – | +78.0% | +40.3% | +21.4% | +17.2% | +17.4% | +10.9% | +8.1% | -5.3% | -16.3% | -2.7% | +8.3% | |
| – | +51.6% | +0.0% | +32.2% | +13.1% | +11.6% | +14.2% | +35.6% | +13.8% | -10.4% | -3.1% | +46.8% | |
| – | +1.9% | +21.3% | +24.5% | -13.7% | +19.7% | +1.1% | -8.3% | +14.1% | -8.8% | +18.4% | +64.7% | |
| – | +19.3% | +10.4% | +17.3% | -8.1% | +19.2% | +9.8% | +1.7% | +11.4% | -7.7% | +10.4% | +55.3% | |
| – | -300.3% | – | – | – | +4.9% | +19.4% | +54.8% | -85.0% | -320.4% | – | – | |
| – | – | – | – | – | – | -29.0% | -95.5% | +2,398.0% | – | – | – | |
| – | -297.5% | – | – | – | +14.5% | +9.0% | +33.8% | -73.3% | -43.9% | -461.6% | – | |
| – | – | – | +30.8% | +1.5% | -62,799.3% | – | +10.7% | -45.5% | -23.8% | -205.0% | – | |
| – | -297.5% | – | – | – | +358.4% | -79.8% | +42.1% | -81.1% | -60.0% | -853.3% | – | |
| – | – | – | – | – | +4.1% | +34.3% | +31.0% | -69.0% | -199.4% | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.